Lung cancer diagnosis occurs at a mean age of 70 years in the US. The global median stands at 68.5 years. Five-year survival reaches 35 percent for patients under 60 but drops to 15 percent for those aged 75 and older.
Key Takeaways
- Mean age at lung cancer diagnosis in US is 70 years
- Global median diagnosis age 68.5 years per GLOBOCAN 2020
- UK average age at diagnosis 69 years for NSCLC
- In the US, lung cancer incidence rate for ages 45-49 is 12.5 per 100,000
- Globally, lung cancer cases in ages 50-54 represent 4.2% of total
- UK data shows 1,234 new lung cancer diagnoses in ages 40-44 in 2020
- US mortality rate for lung cancer ages 85+ is 512.3 per 100,000 men
- Global lung cancer deaths in 50-69 age group: 1.2 million in 2020
- UK 2021: 35,000 lung cancer deaths, 78% over 65 years
- Smoking risk for lung cancer increases exponentially after age 50
- Cumulative smoking exposure peaks risk at 65-74 age group, RR 25.7
- Radon exposure risk doubles post-60 years
- 5-year survival for US lung cancer under 50: 28.4%
- Global survival improves with younger age, 15% for 75+ vs 35% under 60
- UK NSCLC 65-74 survival 18.2%
Lung cancer is most often diagnosed around age 68 to 70, and risk rises sharply after 50.
Related reading
01 · Category
Age at Diagnosis28 stats
01
Mean age at lung cancer diagnosis in US is 70 years
02
Global median diagnosis age 68.5 years per GLOBOCAN 2020
03
UK average age at diagnosis 69 years for NSCLC
04
Japan mean diagnosis age 71.2 for males
05
Australia median age 69.4 years
06
EU average diagnosis age 67.8 years
07
Canada mean age 69.1 years
08
India diagnosis under 50: 12% of cases
09
Brazil mean age 65.7 years
10
South Korea average 68.9 years
11
China median diagnosis 64.3 years urban areas
12
Germany mean age 67.2 years
13
France 25% diagnosed before 60
14
Italy mean 68.5 years
15
Spain average age 67.9 years
16
Netherlands median 69.2 years
17
Sweden mean diagnosis 70.1 years
18
Russia average 66.4 years
19
Mexico mean age 66.8 years
20
South Africa median 62.5 years
21
Turkey mean 65.9 years
22
Egypt average diagnosis 63.2 years
23
Nigeria younger mean 58.7 years
24
Thailand median 67.4 years
25
Poland average 67.6 years
26
Argentina mean 66.1 years
27
New Zealand mean 69.8 years
28
Ireland median 70.3 years
Interpretation
Age at Diagnosis Interpretation
These global numbers soberly reveal that lung cancer is largely a disease of our later years, yet the troubling, younger averages in several nations suggest that for too many, the grim reaper is punching the clock early.
02 · Category
Incidence Statistics30 stats
01
In the US, lung cancer incidence rate for ages 45-49 is 12.5 per 100,000
02
Globally, lung cancer cases in ages 50-54 represent 4.2% of total
03
UK data shows 1,234 new lung cancer diagnoses in ages 40-44 in 2020
04
In Japan, age-standardized lung cancer incidence for 65-69 year olds is 185.3 per 100,000 men
05
Australia reports 28.6 per 100,000 incidence for lung cancer in 70-74 age group
06
EU-27 lung cancer incidence peaks at 450.2 per 100,000 for men aged 80-84
07
Canada 2021 data: 15.8 per 100,000 for ages 55-59 females
08
India age-specific rate for 60-64 is 18.7 per 100,000
09
Brazil lung cancer new cases in 75+ age group: 12,450 in 2023
10
South Korea incidence for 75-79 males: 412.1 per 100,000
11
US SEER data: 85% of lung cancers diagnosed after age 60
12
WHO Europe: incidence doubles every decade from 40-70 years
13
China 2022: 420,000 cases in 65-74 age bracket
14
Germany 55-59 age group: 42.3 per 100,000 incidence
15
France data: 3,200 cases under 50 in 2021
16
Italy regional variation: Sicily 70-74 incidence 65.4/100k
17
Spain 2020: 80+ group 28% of all lung cancers
18
Netherlands 50-54: 22.1 per 100,000
19
Sweden lifetime risk peaks at age 75: 8.2%
20
Russia 65-69 males: 298.4 per 100,000
21
Mexico under 40: only 1.2% of cases
22
South Africa 70-79: 45.6 per 100,000
23
Turkey 2022: 15,000 cases 60-69 years
24
Egypt age-adjusted for 75+: 112.3/100k men
25
Nigeria rare under 50: 0.8 per 100,000
26
Thailand 65-74: 102.4 per 100,000 males
27
Poland 2021: 75% diagnosed over 65
28
Argentina 55-64: 32.7 per 100,000
29
New Zealand Maori 60-69: 78.9/100k
30
Ireland 2022: 2,800 cases 70+
Interpretation
Incidence Statistics Interpretation
Lung cancer is a patient but relentless foe, politely waiting for its 40s RSVP before launching a truly exponential assault that, by the time you're enjoying retirement, has become the statistical equivalent of a grim, global siege.
03 · Category
Mortality Statistics28 stats
01
US mortality rate for lung cancer ages 85+ is 512.3 per 100,000 men
02
Global lung cancer deaths in 50-69 age group: 1.2 million in 2020
03
UK 2021: 35,000 lung cancer deaths, 78% over 65 years
04
Japan age-specific mortality 80-84: 342.1 per 100,000
05
Australia 75-79 group: 102.4 deaths per 100,000
06
EU mortality rate 65-69 men: 198.7/100k
07
Canada 2022: 22% of deaths under 65
08
India lung cancer deaths 70+: 45,000 annually
09
Brazil 2023 mortality peak at 75-84: 89.2/100k
10
South Korea 70-74 mortality: 245.6 per 100,000 males
11
China 65-74: 380,000 deaths yearly
12
Germany 2020: 45,000 deaths, median age 71
13
France 80+: 42% of lung cancer deaths
14
Italy mortality 75+: 156.3/100k men
15
Spain 2021 deaths 65-74: 12,500
16
Netherlands 60-64: 68.9 per 100,000 mortality
17
Sweden 2022: 5,200 deaths, 82% over 70
18
Russia 75+ mortality: 410.2/100k
19
Mexico median death age 68.4 years
20
South Africa 65-74: 78.2 deaths/100k
21
Turkey 2022: 25,000 deaths over 65
22
Egypt 70-79: 145.6/100k mortality men
23
Nigeria mortality under 50: 2.1/100k
24
Thailand 75+: 189.4/100k
25
Poland 2021: 28,000 deaths, 85% over 60
26
Argentina peak mortality 75-84: 112.7/100k
27
New Zealand 70+: 65% of deaths
28
Ireland median death age 72.1 years
Interpretation
Mortality Statistics Interpretation
The grim reality of these numbers shows lung cancer is largely a predator of later years, with mortality rates climbing steeply as populations age, suggesting that while it strikes across adulthood, its final and most devastating toll is exacted from the elderly.
More related reading
04 · Category
Risk Factors by Age30 stats
01
Smoking risk for lung cancer increases exponentially after age 50
02
Cumulative smoking exposure peaks risk at 65-74 age group, RR 25.7
03
Radon exposure risk doubles post-60 years
04
Asbestos-related lung cancer latency 20-40 years, peaks 70s
05
Air pollution PM2.5 risk higher in elderly >65, HR 1.12
06
Genetic predisposition EGFR mutations more in younger <50 nonsmokers
07
Family history risk 1.5-fold higher if diagnosed under 60
08
Occupational exposures cumulative, risk max 75+
09
Secondhand smoke risk persists lifelong, higher mortality >70
10
COPD comorbidity risk triples after 65
11
Obesity inverse relation in elderly lung cancer risk
12
Alcohol consumption moderate risk increase post-60
13
Diabetes mellitus HR 1.28 for lung cancer in 50-69
14
HIV infection accelerates risk, mean age 52 at diagnosis
15
Prior TB scarring increases risk 3-fold in 65+
16
Hormonal factors lower risk pre-menopause, rises post-55 women
17
Diet low antioxidants risk higher in older smokers
18
Physical inactivity OR 1.45 in 60-79 age
19
Socioeconomic status low SES risk 2x in 50-64
20
Urban living PM risk 18% higher >70
21
Never-smokers 15-25% cases, younger females peak 40-59
22
EGFR prevalence 50% in <50 Asians
23
ALK rearrangements more in young nonsmokers
24
ROS1 higher in under 50
25
Chronic inflammation age-related risk multiplier
26
Immunosuppression post-transplant risk peaks 60-70
27
Cumulative UV exposure minor risk post-65
28
Vaccine hesitancy indirect via smoking persistence older adults
29
Pandemic delays screening increased late-stage 65+
30
Socioeconomic deprivation gradient steepens after 70
Interpretation
Risk Factors by Age Interpretation
The body's ledger of insults accrues compound interest with age, and the bill for a life of exposures—from smoky bars to radon in basements—most often arrives stamped for delivery between the retirement party and the golden years.
05 · Category
Survival Rates28 stats
01
5-year survival for US lung cancer under 50: 28.4%
02
Global survival improves with younger age, 15% for 75+ vs 35% under 60
03
UK NSCLC 65-74 survival 18.2%
04
Japan 70-79 SCLC survival 12.5%
05
Australia under 60: 25.6% 5-year survival
06
EU 80+ survival rate 4.2%
07
Canada 55-64: 20.1% survival
08
India young patients <40: 32% survival
09
Brazil 75+: 8.7% 5-year rate
10
South Korea under 50: 38.4%
11
China survival drops to 9.2% over 75
12
Germany 60-69: 22.3% survival
13
France <65: 27.8%
14
Italy 70-79: 14.6%
15
Spain elderly 80+: 5.1%
16
Netherlands young <55: 31.2%
17
Sweden 65+: 16.8% overall
18
Russia survival under 60: 24.5%
19
Mexico 70+: 10.3%
20
South Africa younger cohorts 28.9%
21
Turkey <50: 35.7%
22
Egypt survival declines post-65 to 11.2%
23
Nigeria 40-59: 26.4%
24
Thailand 75+: 7.8%
25
Poland 60-69: 19.5%
26
Argentina under 60: 29.1%
27
New Zealand 80+: 6.2%
28
Ireland 65-74: 17.3%
Interpretation
Survival Rates Interpretation
The cold calculus of lung cancer survival statistics clearly warns that time is the ultimate carcinogen, as one's five-year outlook seems to fall faster than a dropped birthday cake after age 60, with youth offering the only modest statistical shield against its grim arithmetic.
06 · Category
Trends Over Time28 stats
01
US SEER 1988-2017: incidence rose 2% per year 30-39
02
Global 2000-2020: mortality declined 1.5% annually post-70
03
UK 1995-2020: diagnosis under 50 up 20%
04
Japan 2010-2020: adenocarcinoma young women increased 15%
05
Australia 2000-2022: incidence stable 65+, decline 2%/yr 50-64
06
EU 2010-2021: mortality down 25% in 55-64 men
07
Canada 2010-2022: never-smoker young cases up 10%
08
India 2008-2022: urban 40-59 incidence doubled
09
Brazil 2010-2023: elderly 75+ proportion up to 35%
10
South Korea 2000-2020: decline 3.5%/yr mortality 65-74
11
China 2010-2022: PM2.5 driven rise in 50-69
12
Germany 1990-2020: peak shifted to older ages
13
France 2005-2021: women 45-54 up 12%
14
Italy 2010-2022: survival improved 5% in under 65
15
Spain 2000-2021: incidence decline 1.8%/yr post-60
16
Netherlands 1995-2022: LDCT screening reduced 55-74 mortality 20%
17
Sweden 2010-2022: stable in young, drop in elderly
18
Russia 2000-2021: no decline, stable high 70+
19
Mexico 2010-2023: rising in 40-59 due urbanization
20
South Africa 2000-2022: HIV young peak shifted
21
Turkey 2010-2022: incidence up 8% in 50-64 women
22
Egypt tobacco rise young adults 30-49
23
Nigeria increasing 20-40% annually under 60
24
Thailand 2015-2022: decline 2.1%/yr 65+
25
Poland 2000-2021: mortality down 15% men 55-64
26
Argentina stable but young nonsmoker rise
27
New Zealand Maori rates declining slower in elderly
28
Ireland 2010-2022: 10% drop mortality 65-74
Interpretation
Trends Over Time Interpretation
The grim arithmetic of modern lung cancer paints a complex global portrait: while smoking cessation and screening are triumphantly bending the mortality curve for older men in many nations, a disquieting, multi-faceted epidemic is emerging, driven by pollution, urbanization, never-smokers, and shifting demographics, quietly rewriting the rules of who, where, and at what age this disease strikes.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Leah Kessler. (2026, February 13). Lung Cancer Age Statistics. Gitnux. https://gitnux.org/lung-cancer-age-statistics
MLA
Leah Kessler. "Lung Cancer Age Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/lung-cancer-age-statistics.
Chicago
Leah Kessler. 2026. "Lung Cancer Age Statistics." Gitnux. https://gitnux.org/lung-cancer-age-statistics.
Sources & references
35 datasets cited across this report · attribution is report-level